NYSE$KVUE

Kenvue Inc · Q4 2024 earnings

Q4 2024 earnings · · Before market open · Investor relations

Briefing

Kenvue's Q4 2024 results were announced, showing a slight decrease in net sales but growth in organic sales.

Kenvue reported a slight decrease in net sales for Q4 2024, but organic sales grew. The company delivered on its 2024 profit commitments despite headwinds and is focused on accelerating growth and delivering long-term value creation.

  • Net sales decreased 0.1% to $3.7 billion; organic sales grew 1.7%.
  • Diluted EPS was $0.15; adjusted diluted EPS was $0.26.
  • Gross profit margin expanded 80 basis points to 56.5%.
  • Operating income margin was 13.2%.

Headline financials

Total Revenue

$3.66B

Previous: $3.67B-0.2%
EPS (adj)

$0.26

Previous: $0.31-16.1%
Gross Profit Margin

56.5%

No prior period
Adjusted Gross Margin

58.7%

No prior period
Operating Margin

13.2%

No prior period
Adjusted Operating Margin

19.2%

No prior period
Effective Tax Rate

15.3%

No prior period
Adjusted Tax Rate

17.7%

No prior period
R&D Expenses

$106M

No prior period
Net Income

$293M

Previous: $327M-10.4%
Operating Income

$483M

Previous: $460M+5.0%
Gross Profit

$2.07B

Previous: $2.04B+1.3%

Revenue & EPS history

Kenvue · Revenue · Quarterly

$3.66B

Q4 2024-0.2%vs Q4 2023
Beat estimate in 7 of 12 quarters(58%)
ActualEstimate

Revenue by segment

Kenvue · $3.92B total across 3 segments · Q3 2023

  • Self Care
    $1.61B+6.4%
  • Essential Health
    $1.18B+3.0%
  • Skin Health & Beauty
    $1.12B-0.4%

Forward guidance

Kenvue expects to accelerate performance throughout the year, while navigating the dynamic external environment. The company expects to drive further productivity and operational efficiency gains, which will fund planned increases in brand investments, positioning the company to grow adjusted operating margin for the year.

Tailwinds

  • Net sales change of -1% to +1% year-over-year.
  • Organic sales growth of +2% to +4%.
  • Adjusted operating income margin improvement year-over-year.
  • Flat to +2% year-over-year Adjusted diluted earnings per share growth.
  • Drive further productivity and operational efficiency gains

Headwinds

  • A ~3% headwind from foreign currency translation.
  • Mid-single-digit unfavorable impact from foreign currency.
  • This outlook does not include any potential impacts from tariffs introduced in 2025.
  • Unpredictability of the timing and amounts of discrete items such as foreign exchange, acquisitions, or divestitures.
  • Navigating the dynamic external environment

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 12 quarterly earnings reports · overlaid with Q4 2024

Historical avgQ4 2024

+2.0%

Avg return

Earnings day

+3.1%

Avg return

5 days after

+3.0%

Avg return

30 days after

57%

8 / 14 earnings

Positive

+15.7%

Q3 2025

Best reaction

-7.7%

Q3 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.0%-1.2%
Q4 2025+0.9%+2.9%-5.5%
Q3 2025+15.7%+17.5%+18.1%
Q2 2025+1.5%+2.1%-13.2%
Q1 2025+4.3%+2.4%-6.0%
Q4 2024-4.5%+0.8%+12.9%
Q3 2024+5.2%+5.1%+1.5%
Q2 2024+13.4%+15.6%+23.7%
Q1 2024+7.2%+7.7%-2.4%
Q4 2022-0.2%+3.1%+12.9%
Q4 2023-5.8%-6.2%-2.4%
Q3 2023-7.7%-5.7%+2.6%
Q2 2023-4.0%+0.5%-8.5%
Q1 2023-0.5%-0.8%+4.5%
Q3 2022
Q2 2022
Q1 2022
Q4 2021

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro